NYSE : ATR
AptarGroup, Inc. — Key statistics
Healthcare · Medical Instruments & Supplies · United States
Last price 137.2 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 8.72B
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Key statistics
Valuation
| Measure | Value |
|---|
| Market Cap | 8.70B |
| Enterprise Value | 9.90B |
Dates
| Measure | Value |
|---|
| Earnings Date | Oct 29, 2026 |
| Ex-Dividend Date | Nov 12, 2026 |
Shares
| Measure | Value |
|---|
| Current Share Class | 63.39M |
| Shares Outstanding | 63.39M |
| Shares Change (YoY) | -3.82% |
| Shares Change (QoQ) | -0.10% |
| Owned by Insiders (%) | 0.89% |
| Owned by Institutions (%) | 97.17% |
| Float | 62.77M |
Ratios
| Measure | Value |
|---|
| PE Ratio | 33.17 |
| Forward PE | 22.88 |
| PS Ratio | 2.18 |
| Forward PS | 2.15 |
| PB Ratio | 3.33 |
| P/TBV Ratio | 6.58 |
| P/FCF Ratio | 29.51 |
| P/OCF Ratio | 15.17 |
| PEG Ratio | 3.88 |
Evratios
| Measure | Value |
|---|
| EV / Earnings | 37.06 |
| EV / Sales | 2.48 |
| EV / EBITDA | 12.36 |
| EV / EBIT | 20.05 |
| EV / FCF | 33.61 |
Financialposition
| Measure | Value |
|---|
| Current Ratio | 1.50 |
| Quick Ratio | 0.91 |
| Debt / Equity | 0.53 |
| Debt / EBITDA | 1.67 |
| Debt / FCF | 4.81 |
| Interest Coverage | 7.51 |
Financialefficiency
| Measure | Value |
|---|
| Return on Equity (ROE) | 9.79% |
| Return on Assets (ROA) | 6.05% |
| Return on Invested Capital (ROIC) | 9.46% |
| Return on Capital Employed (ROCE) | 12.70% |
| Weighted Average Cost of Capital (WACC) | 5.75% |
| Revenue Per Employee | $285,088 |
| Profits Per Employee | $19,085 |
| Employee Count | 14,000 |
| Asset Turnover | 0.78 |
| Inventory Turnover | 4.54 |
Taxes
| Measure | Value |
|---|
| Income Tax | 92.80M |
| Effective Tax Rate | 25.73% |
Stockprice
| Measure | Value |
|---|
| Beta (5Y) | 0.34 |
| 52-Week Price Change | +10.37% |
| 50-Day Moving Average | 125.86 |
| 200-Day Moving Average | 126.95 |
| Relative Strength Index (RSI) | 77.37 |
| Average Volume (20 Days) | 515,268 |
Shortselling
| Measure | Value |
|---|
| Short Interest | 2.07M |
| Short Previous Month | 1.94M |
| Short % of Shares Out | 3.27% |
| Short % of Float | 3.30% |
| Short Ratio (days to cover) | 4.15 |
Incomestatement
| Measure | Value |
|---|
| Revenue | 3.99B |
| Gross Profit | 1.43B |
| Operating Income | 493.90M |
| Pretax Income | 360.67M |
| Net Income | 267.19M |
| EBITDA | 801.39M |
| EBIT | 493.90M |
| Earnings Per Share (EPS) | $4.14 |
Balancesheet
| Measure | Value |
|---|
| Cash & Cash Equivalents | 212.30M |
| Total Debt | 1.42B |
| Net Cash | -1.21B |
| Net Cash Per Share | -$19.03 |
| Equity (Book Value) | 2.66B |
| Book Value Per Share | 41.24 |
| Working Capital | 613.98M |
Cashflow
| Measure | Value |
|---|
| Operating Cash Flow | 573.47M |
| Capital Expenditures | -278.78M |
| Depreciation & Amortization | 307.49M |
| Net Borrowing | 179.33M |
| Free Cash Flow | 294.69M |
| FCF Per Share | $4.65 |
Margins
| Measure | Value |
|---|
| Gross Margin | 35.79% |
| Operating Margin | 12.37% |
| Pretax Margin | 9.04% |
| Profit Margin | 6.69% |
| EBITDA Margin | 20.08% |
| EBIT Margin | 12.37% |
| FCF Margin | 7.38% |
Dividends
| Measure | Value |
|---|
| Dividend Per Share | $2.00 |
| Dividend Yield | 1.46% |
| Dividend Growth (YoY) | 6.01% |
| Years of Dividend Growth | 32 |
| Payout Ratio | 48.36% |
| FCF Payout Ratio | 43.02% |
| Buyback Yield | 3.82% |
| Shareholder Yield | 5.28% |
| Earnings Yield | 3.01% |
| FCF Yield | 3.39% |
Analystforecasts
| Measure | Value |
|---|
| Price Target | $163.25 |
| Price Target Difference | 18.99% |
| Analyst Consensus | Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (3Y) | 4.84% |
| EPS Growth Forecast (3Y) | 6.17% |
Stocksplits
| Measure | Value |
|---|
| Last Split Date | May 10, 2007 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
| Measure | Value |
|---|
| Altman Z-Score | 3.99 |
| Piotroski F-Score | 6 |
Fairvalue
| Measure | Value |
|---|
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside | |